ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
145 | (±¹³»)KCIÈĺ¸ | Ä¡À¯µÈ ´ë»óÆ÷Áø ºÎÀ§¿¡ ¹ß»ýÇÑ ÆÇ»ó°Ç¼±: Wolf¡¯s Isotopic Response |
144 | (±¹³»)KCIÈĺ¸ | Àü½Å°í¸§¹°Áý°Ç¼± ȯÀÚ¿¡¼ cyclosporine Ä¡·á Áß ¹ß»ýÇÑ Kaposi ¼öµÎ ¸ð¾ç¹ßÁø |
143 | (±¹³»)SCIE | Comparison of the treatment outcomes of photodynamic therapy and ingenol mebutate in Bowen¡¯s disease: A retrospective observational study |
142 | (±¹¿Ü)SCI | Immune tolerance of tissue-engineered skin produced with allogeneic or xenogeneic fibroblasts and syngeneic keratinocytes grafted on mice |
141 | (±¹³»)KCIÈĺ¸ | °Ç¼±°üÀý¿°À» µ¿¹ÝÇÑ °Ç¼± ȯÀÚ¿¡¼ adalimumab Ä¡·á Áß ¹ß»ýÇÑ ±Þ¼º °ñ¼ö¼º¹éÇ÷º´ 1¿¹ |
140 | (±¹¿Ü)SCI | A Case of Interstitial Lung Disease and Autoimmune Thyroiditis Associated with Ustekinumab |
139 | (±¹³»)KCI | ÃÖ±Ù 11³â°£(2006¡2016) °æ±â µ¿³²ºÎ Áö¿ªÀÇ ÁÖ¿ä ÇǺξǼºÁ¾¾ç°ú ÇǺξÏÀü±¸Áõ¿¡ °üÇÑ Åë°èÀû °íÂû |
138 | (±¹³»)SCIE | Anti-wrinkle efficacy of cross-linked hyaluronic acid-based micropatch with acetyl hexapeptide-8 and epidermal growth factor on Asian skin |
137 | (±¹¿Ü)SCI | Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphigoid in patients with diabetes |
136 | (±¹³»)SCOPUS | Vanishing Bile Duct Syndrome°ú µ¿¹ÝµÇ¾î ³ªÅ¸³ Stevens-Johnson Syndrome 1¿¹ |
Copyright ¨Ï chamc, All rights reserved.